US › Healthcare

MiniMed Group, Inc. Common Stock (MMED)

US · Healthcare · Medical Instruments & Supplies

$18.99-0.58%
Last close · 2026-08-04

Latest quarter · ended 2026-04-30

Revenue
$837.0M
Net profit
$-183.0M
EPS
$-0.60
EPS estimate
$-0.22
Net margin
-21.9%

EPS came in at -0.60 against a street estimate of -0.22 — a miss of 172.7%.

Key statistics

Market cap
$5.07B
Forward P/E
0.0
P/B
1.40
Book value
$12.86
EPS (TTM)
$-1.30
52-week high
$20.48
52-week low
$10.65
50-day MA
$14.82
200-day MA
$14.44

Analyst view

with an average price target of $21.00.

Shareholding

Insiders
90.74%
Institutions
12.32%

Largest institutional holders

FundStake
Massachusetts Financial Services Company2.45%
Longaeva Partners L.P.1.13%
Citadel Advisors Llc1.02%
Millennium Management LLC0.92%
Sessa Capital, L.P0.71%
Alyeska Investment Group, L.P.0.71%
Hood River Capital Management LLC0.54%
FMR Inc0.49%

Recent filings & reports

DocumentDate
Annual report FY20262026-06-29
Board / officer change · Q2 20262026-06-29
Results announced · Q2 20262026-06-03
Board / officer change · Q2 20262026-05-18
Reg FD disclosure · Q2 20262026-04-27
Quarterly report · Q1 20262026-04-17

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for MiniMed Group, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.